JAMA Otolaryngology-Head & Neck Surgery
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 13, 2020
Media advisory: The full study and video are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2019.4328?guestAccessKey=99f5c0f9-05e4-4406-a0a6-4626c4505163&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021320
What The Study Did: This small trial examined the feasibility and effectiveness of injecting cells with regenerative properties that are from a patient’s fat tissue into scarred vocal cords of patients who had difficulty speaking.
Authors: Alexia Mattei, M.D., of La Conception University Hospital in Marseille, France, is the corresponding author.
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Video embed code: